These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9655182)

  • 1. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse.
    Kuznetsov AV; Winkler K; Wiedemann FR; von Bossanyi P; Dietzmann K; Kunz WS
    Mol Cell Biochem; 1998 Jun; 183(1-2):87-96. PubMed ID: 9655182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of Mitochondrial Calcium Overload via MKT077-Induced Inhibition of Glucose-Regulated Protein 75 Alleviates Skeletal Muscle Pathology in Dystrophin-Deficient
    Dubinin MV; Stepanova AE; Mikheeva IB; Igoshkina AD; Cherepanova AA; Talanov EY; Khoroshavina EI; Belosludtsev KN
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice.
    Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition.
    Percival JM; Siegel MP; Knowels G; Marcinek DJ
    Hum Mol Genet; 2013 Jan; 22(1):153-67. PubMed ID: 23049075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Mikheeva IB; Sharapov MG; Belosludtsev KN
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165674. PubMed ID: 31926263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin deficiency disrupts muscle clock expression and mitochondrial quality control in
    Hardee JP; Caldow MK; Chan ASM; Plenderleith SK; Trieu J; Koopman R; Lynch GS
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C288-C296. PubMed ID: 34191629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyradical damage and mitochondrial enzyme activities in the mdx mouse.
    Hauser E; Höger H; Bittner R; Widhalm K; Herkner K; Lubec G
    Neuropediatrics; 1995 Oct; 26(5):260-2. PubMed ID: 8552217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
    Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle.
    Ruegg UT; Nicolas-Métral V; Challet C; Bernard-Hélary K; Dorchies OM; Wagner S; Buetler TM
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S155-61. PubMed ID: 12206810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempting to Compensate for Reduced Neuronal Nitric Oxide Synthase Protein with Nitrate Supplementation Cannot Overcome Metabolic Dysfunction but Rather Has Detrimental Effects in Dystrophin-Deficient mdx Muscle.
    Timpani CA; Trewin AJ; Stojanovska V; Robinson A; Goodman CA; Nurgali K; Betik AC; Stepto N; Hayes A; McConell GK; Rybalka E
    Neurotherapeutics; 2017 Apr; 14(2):429-446. PubMed ID: 27921261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse.
    McArdle A; Edwards RH; Jackson MJ
    Neuromuscul Disord; 1995 Nov; 5(6):445-56. PubMed ID: 8580726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of dystrophin is associated with altered integration of the mitochondria and ATPases in slow-twitch muscle cells of MDX mice.
    Braun U; Paju K; Eimre M; Seppet E; Orlova E; Kadaja L; Trumbeckaite S; Gellerich FN; Zierz S; Jockusch H; Seppet EK
    Biochim Biophys Acta; 2001 Jun; 1505(2-3):258-70. PubMed ID: 11334790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
    Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
    J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy.
    Terrill JR; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2015 Sep; 66():141-8. PubMed ID: 26239309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
    Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
    Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.